VITARNA
Owned by0xF5307…e5Ac2
Project Description
Artan Bio has proposed a novel approach to address genetic and age-related diseases caused by nonsense mutations. These mutations lead to premature protein translation stops, resulting in incomplete and nonfunctional proteins. The solution involves an engineered suppressor system that specifically recognizes these codons and restores normal protein translation.Michael Torres
Research Lead
Artan Bio, LLC
Organisation
$91,300.00
Experiment Cost
Project Progress
Timeline
Loading...